Advertisement
Screener

RA PHARMACEUTICALS, INC. Proceeds from Convertible Debt

RA PHARMACEUTICALS, INC. Proceeds from Convertible Debt

RA PHARMACEUTICALS, INC. reported Proceeds from Convertible Debt of $5.00 million for the 12-month period ending 2015-12-31, per its 10-K filed 2018-03-14.

Discontinued › Cash Flow › Financing Activities

us-gaap:ProceedsFromConvertibleDebt · last filed 2018-03-14

  • RA PHARMACEUTICALS, INC. proceeds from convertible debt for the quarter ending 2015-12-31 was $0.00.
  • RA PHARMACEUTICALS, INC. proceeds from convertible debt for fiscal 2015 was $5.00M.
Period endProceeds from Convertible Debt 3 monthProceeds from Convertible Debt 9 monthProceeds from Convertible Debt 12 month
2015-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-14
$5.00M
10-K · filed 2018-03-14
2015-09-30$5.00M
10-Q · filed 2016-11-29